Inflammatory infiltrates of experimental mammary cancers.

The purpose of this review was to summarize observations on the type and function of inflammatory infiltrates of mouse mammary tumors and to speculate on the underlying mechanisms and the significance of infiltrates to mammary tumor biology. Although the major conclusion is that much more work is needed, certain themes seem to be emerging. The number of infiltrating cells can be very high but is unrelated to biological behavior of the tumors. What seems to be important is the relative contributions of inflammatory cell subsets. In the case of T-cell subsets and NK cells, the infiltrates from tumors of long-term cell lines so far seem uninformative. The general characteristics are similar to those of infiltrates from rapidly proliferating, normal mammary tissues. These characteristics do not correlate with diverse biological behavior or malignant potential. A more informative model appears to be one in which the development of tumors from preneoplastic tissue can be observed. Here our attention is currently focused on NK cells. By contrast, the correlation between activated TAM and metastatic behavior suggests that our transplantable MMT lines may be biologically relevant in the study of infiltrating macrophages. We are especially interested in the role of TAM in the generation of tumor cell variability. Overall, our data indicate that the host infiltrate is another manifestation of both inter- and intra-tumor heterogeneity and, as such, is not simply a response to, but, rather, a part of the tumor ecosystem. Unraveling the cellular and molecular mechanisms that govern the inflammatory cell component of tumors should provide insight into the types of cellular interactions that result in tumor development and progression.

[1]  H. Macdonald,et al.  Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.

[2]  D. Durant,et al.  Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells. , 1983, Journal of immunology.

[3]  J. Mulé,et al.  Selective localization of radiolabeled immune lymphocytes into syngeneic tumors. , 1979, Journal of immunology.

[4]  C. Boone,et al.  Changes in the homing properties of labeled lymphoid cells caused by solid tumor growth. , 1974, Cellular immunology.

[5]  R. Williams,et al.  T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. , 1980, Cancer research.

[6]  G. Wolterink,et al.  Effects of endotoxin‐treatment on inflammatory cell infiltrates in murine meth A sarcoma , 1985, The Journal of pathology.

[7]  R. Williams,et al.  Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe. , 1980, Cellular immunology.

[8]  K. A. Wall,et al.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.

[9]  I. McKenzie,et al.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions. , 1982, Immunology.

[10]  W. Wei,et al.  Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues. , 1986, Cancer research.

[11]  H. Whitwell,et al.  Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. , 1984, British Journal of Cancer.

[12]  I. Weissman,et al.  Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition. , 1982, Journal of immunology.

[13]  G. Heppner,et al.  Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100. , 1984, Cancer research.

[14]  F. Orr,et al.  Chemotaxis of large granular lymphocytes. , 1986, Journal of immunology.

[15]  J. Vaage,et al.  Morphological observations during developing concomitant immunity against a C3H/He mammary tumor. , 1985, Cancer research.

[16]  G. Heppner,et al.  In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors. , 1978, Journal of immunology.

[17]  W. Nelson-Rees,et al.  Bovine leukemia: establishment and morphologic characterization of continuous cell suspension culture, BL-1. , 1968, Journal of the National Cancer Institute.

[18]  R. Snyderman,et al.  Inhibitors of monocyte responses to chemotaxins are associated with human neoplasms. , 1982, Advances in experimental medicine and biology.

[19]  H. Whitwell,et al.  Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. , 1984, British Journal of Cancer.

[20]  Craig W. Reynolds,et al.  Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer. , 1984, Cellular immunology.

[21]  H. Muller,et al.  Lymphocyte migration during the development of regional lymph node anergy in experimental tumor growth. , 1983, Cellular immunology.

[22]  G. Heppner,et al.  Heterogeneity of expression and induction of mouse mammary tumor virus antigens in mouse mammary tumors. , 1982, Cancer research.

[23]  P. Beverley,et al.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. , 1984, British Journal of Cancer.

[24]  L. Milas,et al.  Stimulated granulocytopoiesis in mice bearing fibrosarcoma. , 1972, European journal of cancer.

[25]  M. Kasai,et al.  A glycolipid on the surface of mouse natural killer cells , 1980, European journal of immunology.

[26]  J. Hurlimann,et al.  Mononuclear cells infiltrating human mammary carcinomas: Immunohistochemical analysis with monoclonal antibodies , 1985, International journal of cancer.

[27]  E. Unanue,et al.  Chemotaxis of rat lymphocytes. , 1977, Journal of immunology.

[28]  R. Snyderman,et al.  Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal , 1977 .

[29]  E. Cronkite,et al.  Tumor-induced granulopoiesis unrelated to colony-stimulating factor. , 1983, Blood.

[30]  P. Steerenberg,et al.  Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. , 1985, Journal of immunology.

[31]  P. Wilkinson Chemotaxis and inflammation , 1974 .

[32]  A. Miller,et al.  Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocaricinoma. i. characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity , 1984, International journal of cancer.

[33]  A. Mantovani,et al.  Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues , 1983, International journal of cancer.

[34]  S. Haskill,et al.  Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells. , 1982, British Journal of Cancer.

[35]  J. Varani,et al.  Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. , 1985, Journal of immunology.

[36]  B. Zwilling,et al.  Prostaglandin regulation of macrophage function: effect of endogenous and exogenous prostaglandins. , 1982, Cellular immunology.

[37]  I. Weissman,et al.  A cell-surface molecule involved in organ-specific homing of lymphocytes , 1983, Nature.

[38]  C. Yu,et al.  Lymphocyte chemotactic activity of human interleukin 1. , 1984, Journal of immunology.

[39]  P. Allavena,et al.  In vitro migration of human large granular lymphocytes. , 1985, Journal of immunology.

[40]  J. Berman,et al.  Induction of human T lymphocyte motility by interleukin 2. , 1985, Journal of immunology.

[41]  I. Weissman,et al.  Differences in in vivo distribution and homing of T cell subsets to mucosal vs nonmucosal lymphoid organs. , 1983, Journal of immunology.

[42]  J. Mulé,et al.  Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours. , 1982, The American journal of pathology.

[43]  S. Weitzman,et al.  Phagocytes as carcinogens: malignant transformation produced by human neutrophils. , 1985, Science.

[44]  D. Parrott,et al.  Locomotion of human lymphoid cells. I. Effect of culture and con A on T and non-T lymphocytes. , 1977, Cellular immunology.

[45]  C. Rosse,et al.  Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma. , 1985, Cancer research.

[46]  K. von der Mark,et al.  Laminin and its receptor. , 1985, Biochimica et biophysica acta.

[47]  S. Weitzman,et al.  Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis. , 1982, Journal of immunology.

[48]  L. Liotta,et al.  Identification and partial characterization of a low-molecular-weight inhibitor of leukotaxis from fibrosarcoma cells. , 1984, Cancer research.

[49]  E. M. Lawler,et al.  Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene‐induced sarcomas , 1980, International journal of cancer.

[50]  E. Lord,et al.  Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model. , 1984, Cellular immunology.

[51]  L. Herzenberg,et al.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views , 1980, The Journal of experimental medicine.

[52]  S. Eccles,et al.  Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.

[53]  R. Herberman,et al.  The Reticuloendothelial System , 2012, Springer US.

[54]  H. Svaar,et al.  Content and distribution of macrophages and lymphocytes in solid malignant human tumours , 1979, International journal of cancer.

[55]  D. Dexter,et al.  Heterogeneity of tumor cells from a single mouse mammary tumor. , 1978, Cancer research.

[56]  S. Carter,et al.  Haptotaxis and the Mechanism of Cell Motility , 1967, Nature.

[57]  F. Miller,et al.  Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays. , 1980, Journal of the National Cancer Institute.

[58]  R. Daynes,et al.  Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. , 1984, Journal of immunology.

[59]  R. Daynes,et al.  Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. , 1985, Journal of immunology.

[60]  D. Haskard,et al.  Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. , 1986, Journal of immunology.

[61]  M. Moore,et al.  Human tumor-infiltrating lymphocytes: a marker of host response. , 1985, Seminars in hematology.

[62]  R. Evans Macrophage accumulation in primary and transplanted tumors growing in C5‐deficient B10.D2/oSn mice , 1980, International journal of cancer.

[63]  W. Becker,et al.  Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies. , 1983, Archives of oral biology.

[64]  H. Broxmeyer,et al.  Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. , 1978, Blood.

[65]  L. Kaizer,et al.  POST‐MITOTIC AGE OF MONONUCLEAR CELLS MIGRATING INTO TA‐3(St) SOLID TUMORS , 1977, Cell and tissue kinetics.

[66]  F. Miller,et al.  In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors. , 1978, Journal of immunology.

[67]  I. Fidler,et al.  Macrophage content of metastatic and nonmetastatic rodent neoplasms. , 1981, Journal of immunology.

[68]  T. Yoshimura,et al.  Chemotactic macrophage subpopulations defined by macrophage chemotactic factors from delayed hypersensitivity reaction sites. , 1983, Journal of Immunology.

[69]  C. Rosse,et al.  Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma. , 1982, Cancer research.

[70]  W. Troll,et al.  The role of oxygen radicals as a possible mechanism of tumor promotion. , 1985, Annual review of pharmacology and toxicology.

[71]  J. Woodruff,et al.  Lymphocyte recognition of lymph node high endothelium. IV. Cell surface structures mediating entry into lymph nodes. , 1982, Journal of immunology.

[72]  J. McCarthy,et al.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro , 1984, The Journal of cell biology.

[73]  G. Heppner,et al.  T cell locomotion in the tumor microenvironment. I. A collagen-matrix assay. , 1985, Journal of Immunology.

[74]  A. Theodore,et al.  Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. , 1985, Cellular immunology.

[75]  D. V. Van Epps,et al.  Human T-lymphocyte chemotactic activity: nature and production in response to antigen. , 1986, Cellular immunology.

[76]  E. Leonard,et al.  Abnormal monocyte chemotactic response in cancer patients. , 1974, Journal of the National Cancer Institute.

[77]  S. Weitzman,et al.  Mutation caused by human phagocytes. , 1981, Science.

[78]  I. Weissman,et al.  Cell surface molecule associated with lymphocyte homing is a ubiquitinated branched-chain glycoprotein. , 1986, Science.

[79]  A. Fulton Effects of indomethacin on the growth of cultured mammary tumors , 1984, International journal of cancer.

[80]  M. Wicha,et al.  Macrophages express cell surface laminin. , 1983, Experimental cell research.

[81]  P. Bland,et al.  Immunohistologic analysis of the T-cell and macrophage infiltrate in 1,2-dimethylhydrazine-induced colon tumors in the rat. , 1985, Journal of the National Cancer Institute.

[82]  R. Simmons,et al.  Maturation of cytotoxic T cells within sponge matrix allografts. , 1983, Journal of immunology.

[83]  D. Medina Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. , 1976, Journal of the National Cancer Institute.

[84]  G. Heppner,et al.  Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors. , 1983, Journal of immunology.

[85]  S. Tlouzeau,et al.  Enhancement by serotonin of intra-tumour penetration of spleen cells. , 1984, British Journal of Cancer.

[86]  C. Hardy,et al.  High proliferation of granulocyte-macrophage progenitors in tumor-bearing mice. , 1983, Cancer research.

[87]  P. Lala,et al.  Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. , 1985, Cellular immunology.

[88]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[89]  L. Weiss Principles of metastasis , 1985 .